Article
[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease].
Kardiologiia - 1 Jan 2011
Komarov A L, Panchenko E P, Donnikov A E, Shakhmatova O O, Dzhalilova G V, Iliushchenko T A
Abstract excerpt
Aim of the study was to elucidate genetic and drug factors affecting efficacy of clopidogrel in patients with ischemic heart disease - inhabitants of central region of Russian Federation. We included 399 patients with IHD (79% men, mean age 58.3+/-9 years) receiving long term therapy with clopidogrel 75 mg/day (during stable manifestations of the disease) or 75-150 mg/day in combination with aspirin (in relation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.